Professor

Michelle Haber

AM FAA FAHMS

Michelle Haber
Image Description
Michelle Haber is a world-renowned authority in the field of childhood cancer research and a key leader of the Australian biomedical research community. She has made fundamental discoveries in the area of drug resistance in neuroblastoma, and has pioneered molecular diagnostics and precision medicine for Australian children with leukaemia and other high-risk cancers. Haber's work has had a major impact on the global research community, and been translated into new therapeutics and changed models of care for Australian child cancer sufferers.

Fields of research

31 BIOLOGICAL SCIENCES
  • 3213 PAEDIATRICS
32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3211 ONCOLOGY AND CARCINOGENESIS
    • 321101 Cancer Cell Biology
    • 321102 Cancer Diagnosis
    • 321104 Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
    • 321108 Molecular Targets
  • 3215 REPRODUCTIVE MEDICINE

For full list of research codes, please visit the ARC Website .

Expertise type

  • Medical Sciences
  • Cancer
  • Cancer Biology
  • Cancer Therapy
  • Oncology

Please contact fellowship@science.org.au to request any updates to the data.